California Drug Price Measure Fiercely Opposed By Pharmaceutical Industry
(By Pauline Bartolone for California Healthline) Drugmakers are waging a fierce campaign against a proposed California law that would require
Read More
Part D/Prescription Drugs
Flu-Miffed: Piecing Together Clues On How FluMist Lost Its Place In The Flu-Fighting Toolbox
(By Julie Appleby for Kaiser Health News) What led to the abrupt fall of FluMist — the nasal spray version
Read MorePrice Relief, Innovation, and Competition for Essential Drugs Act will it Lower Drug Costs?
U.S. Representative Janice Schakowsky, (D-IL 9th District), introduced the bill called Price Relief, Innovation, and Competition for Essential Drugs Act
Read MoreThe FDA to Review Diabetes Drugs for Additional Benefits
On June 28th an advisory panel to the U.S. Food and Drug Administration (FDA) will vote on whether a diabetes
Read MoreIs Medicare’s Proposed Rule Violating Obamacare?
In a letter to Senate Finance Committee Chairman Charles Grassley, R-IA, a group of health providers and patient advocates expressed
Read MoreMedicare Part D Spending on Compounded Drugs up 625 Percent
In a report released Wednesday by the Office of the Inspector General at the US Health & Human Services, finds
Read MoreFilling A Prescription? You Might Be Better Off Paying Cash
(By Julie Appleby for Kaiser Health News) Some consumers who use health insurance copays to buy prescription drugs are paying
Read MoreCalls for Patient-Centered, Value-Driven Health Care
In the opinion column “Let’s Keep Progress on Cancer Moving” on the Morning Consult website, Stephen Ubl, chief executive officer
Read MoreThe Administration to Help the Supreme Court Decide on a Case
The U.S. Supreme Court has asked the Obama administration for its views on a rule (Biologics Price Competition and Innovation
Read MoreWhat is the March-In Right
Currently under federal law, The march-in right allows the US National Institutes of Health (NIH) to require a drug maker
Read More